Uric acid levels in serum in the assessment of some psychiatric disorders in India

• Published in: Journal of medicine, radiology, pathology and surgery radiology, pathology and surgery, 2015, Vol.1 (1), p.9-12
• Main Authors: Nasar, Md Abu, Subhani, Tarannum Fatima, Gupta, R. P., Naseer, Arif, Subhani, Syed Saif
• Format: Article
• Language: English
• Subjects: Alzheimer's disease; Antioxidants; Behavior disorders; Bipolar disorder; Dementia; Enzymes; Females; Males; Multiple sclerosis; Parkinson's disease; Plasma; Psychiatry; Psychosis; Psychotropic drugs; Schizophrenia; Studies; Tranquilizers; Uric acid
• ISSN: 2395-2075; 2395-2075
• DOI: 10.15713/ins.jmrps.3

The increasing number of latent and manifest hyperuricemia is important concerning differential diagnosis in neurological and psychiatric diseases. The pathological importance of hyperuricemia in these diseases is particularly unknown. Previous studies have shown that uric acid (UA) estimation in cerebrospinal fluid was made with neurological and psychiatric diseases. Monitoring serum UA levels, a relatively inexpensive and easily available test, may prove to be a useful adjunct in the assessment of certain indices of certain psychiatric illness. Tranquilizers like 1,4 - benzodiazepine (purinergic) are shown to decrease xanthine oxidase activity initially and may cause fluctuations in serum UA levels. In the present study, an attempt was made to understand the effect of tranquilizers on serum UA levels in different psychiatric conditions. A total of 40 cases (22 males and 18 females) of manic depressive psychosis and Schizophrenia who were undergoing treatment with different tranquilizers from the Psychiatric Hospital, Patna, India and 20 healthy controls (12 males and 8 females) not using any tranquilizers were included in the study. The serum UA levels were significantly elevated (P < 0.05) in these patients receiving treatment with tranquilizers. The levels of UA in male patients were significantly higher when compared with females and also over male controls (P < 0.01). In female patients UAs levels are raised but not significant (P > 0.05) over control females. This preliminary study does indicate that serum UA levels do change with the administration of these drugs. Nature, gender, duration and the type of drugs used and their individual effects on different psychiatric disorders will be discussed.